Target Information
AorticLab, established in 2017, is a pioneering startup focused on innovating and enhancing treatment methods for patients suffering from aortic valve stenosis. The company recently completed a capital increase of €1.3 million, primarily funded by investors from the Doorway platform, members of the Italian Angels for Growth (IAG), and the Investors' Club. This influx of capital enables AorticLab to further advance its promising projects in the development pipeline.
Among the investors in this capital raise were prominent industry stakeholders and angel investors who previously contributed over €800,000 in May. This investment supports the completion of a
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Similar Deals
CDP Venture Capital → Arsenale Bioyards
2025
Utopia SIS and Pariter Partners → LighthouseBiotech
2023
Italian Angels for Growth, Club degli Investitori, Doorway
invested in
AorticLab
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $1M